Nivolumab (metastatic cancer); Injection concentrate for I.V. infusion 40 mg in 4 mL, Injection concentrate for I.V. infusion 100 mg in 10 mL; Opdivo^®; Ipilimumab (metastatic cancer); Injection concentrate for I.V. infusion 50 mg in 10 mL, Injection concentrate for I.V. infusion 200 mg in 40 mL; Yervoy^®

Page last updated: 14 November 2025

• Public Summary Document (PSD) July 2025 PBAC Meeting - (PDF 779KB)
• Public Summary Document (PSD) July 2025 PBAC Meeting - (Word 209KB)